REVANCE THERAPEUTICS INC - NOTE 1.750% 2/1

Q2 2021 13F Holders as of 6/30/2021

Type / Class
Debt / NOTE 1.750% 2/1
Number of holders
25
Total Principal
262M
Shares change
+4.09M
Total reported value, excl. options
$307M
Value change
+$5.15M
Put/Call ratio
0
Number of buys
11
Number of sells
-11
Price
$1.17
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.